(Q35597062)

9 August 2017

1 reference

title

Autologous stem cell transplantation in multiple myeloma patients <60 vs >/=60 years of age. (English)

1 reference

9 August 2017

10

Gertz MA

1 reference

9 August 2017

23

Wiernik PH

1 reference

9 August 2017

Reece DE

1

1 reference

9 August 2017

Bredeson C

2

1 reference

9 August 2017

Pérez WS

3

1 reference

9 August 2017

Jagannath S

4

1 reference

9 August 2017

Zhang MJ

5

1 reference

9 August 2017

Ballen KK

6

1 reference

9 August 2017

Elfenbein GJ

7

1 reference

9 August 2017

Freytes CO

8

1 reference

9 August 2017

Gale RP

9

1 reference

9 August 2017

Gibson J

11

1 reference

9 August 2017

Giralt SA

12

1 reference

9 August 2017

Keating A

13

1 reference

9 August 2017

Kyle RA

14

1 reference

9 August 2017

Maharaj D

15

1 reference

9 August 2017

Marcellus D

16

1 reference

9 August 2017

McCarthy PL

17

1 reference

9 August 2017

Milone GA

18

1 reference

9 August 2017

Nimer SD

19

1 reference

9 August 2017

Pavlovsky S

20

1 reference

9 August 2017

To LB

21

1 reference

9 August 2017

Weisdorf DJ

22

1 reference

9 August 2017

Wingard JR

24

1 reference

9 August 2017

Vesole DH

25

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

Bone Marrow Transplantation

9 August 2017

published in

1 reference

9 August 2017

volume

32

1 reference

9 August 2017

issue

12

1 reference

9 August 2017

page(s)

1135-1143

1 reference

Autologous blood and marrow transplantation in patients 60 years and older

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704288

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704288

The role of autologous transplantation in patients with multiple myeloma aged 65 years and over

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704288

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704288

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704288

Comparison of 200 mg/m(2) melphalan and 8 Gy total body irradiation plus 140 mg/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergrou

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704288

A randomized trial of maintenance interferon following high-dose chemotherapy in multiple myeloma: long-term follow-up results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704288

Maintenance therapy with alternate-day prednisone improves survival in multiple myeloma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704288

Consolidation therapy of multiple myeloma with thalidomide-dexamethasone after intensive chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704288

Immunotherapy of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704288

Novel therapies targeting the myeloma cell and its bone marrow microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704288

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704288

7 January 2021

Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704288

7 January 2021

Reduced progression-free survival in elderly patients receiving intensification with autologous peripheral blood stem cell reinfusion for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704288

7 January 2021

Testing for centre effects in multi-centre survival studies: a Monte Carlo comparison of fixed and random effects tests

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704288

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704288

1 reference

Dimensions Publication ID

9 August 2017

1035001236

0 references

1 reference